- Home
- DARE vs PYN Comparison
DARE vs PYN Comparison
Compare DARE & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- PYN
- Stock Information
- Founded
- DARE 2015
- PYN 2002
- Country
- DARE United States
- PYN United States
- Employees
- DARE N/A
- PYN N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- PYN Investment Managers
- Sector
- DARE Health Care
- PYN Finance
- Exchange
- DARE Nasdaq
- PYN Nasdaq
- Market Cap
- DARE 26.3M
- PYN 30.1M
- IPO Year
- DARE N/A
- PYN N/A
- Fundamental
- Price
- DARE $2.41
- PYN $5.33
- Analyst Decision
- DARE Strong Buy
- PYN
- Analyst Count
- DARE 3
- PYN 0
- Target Price
- DARE $12.50
- PYN N/A
- AVG Volume (30 Days)
- DARE 39.6K
- PYN 19.9K
- Earning Date
- DARE 08-11-2025
- PYN 01-01-0001
- Dividend Yield
- DARE N/A
- PYN 5.07%
- EPS Growth
- DARE N/A
- PYN N/A
- EPS
- DARE N/A
- PYN N/A
- Revenue
- DARE $25,909.00
- PYN N/A
- Revenue This Year
- DARE $99,756.91
- PYN N/A
- Revenue Next Year
- DARE $119.77
- PYN N/A
- P/E Ratio
- DARE N/A
- PYN N/A
- Revenue Growth
- DARE N/A
- PYN N/A
- 52 Week Low
- DARE $2.35
- PYN $4.84
- 52 Week High
- DARE $4.60
- PYN $6.60
- Technical
- Relative Strength Index (RSI)
- DARE 35.15
- PYN 54.42
- Support Level
- DARE $2.37
- PYN $5.25
- Resistance Level
- DARE $2.54
- PYN $6.13
- Average True Range (ATR)
- DARE 0.11
- PYN 0.11
- MACD
- DARE -0.02
- PYN 0.01
- Stochastic Oscillator
- DARE 17.50
- PYN 11.29
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.